Epithelial–Mesenchymal Transition in Cutaneous Fibrosis Disease: From Mechanisms to Therapy
June 2026
in “
Frontiers in Immunology
”
Studysummary This review discusses the role of epithelial–mesenchymal transition in cutaneous fibrotic disorders and highlights potential molecular targets for therapy, but reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →